Sector News

Report: Private equity firms eyeing Bayer MaterialScience

October 23, 2014
Chemical Value Chain
Private equity firms are mulling possible offers for Bayer MaterialScience (BMS), the German life science company’s major polyurethanes and polycarbonates business, according to a report on Reuters, citing sources familiar with the situation. Analysts have already speculated that BMS, which could be worth around €10 billion ($12.7 billion) on a debt-free basis when it is separated from Bayer next year, might also attract an industry buyer keen to establish a leadership position in BMS’s value-added plastics markets. 
 
> Read the full article on the Chemical Week website
 
By Natasha Alperowicz
 

comments closed

Related News

October 2, 2022

Trinseo announces potential closure of Boehlen, Germany Styrene Plant

Chemical Value Chain

Trinseo (NYSE: TSE), a specialty material solutions provider, announced it has initiated an information and consultation process with the Works Council of Trinseo Deutschland GmbH regarding the potential closure of its styrene monomer production site in Boehlen, Germany.

October 2, 2022

Celeste Mastin appointed H.B. Fuller President and CEO, succeeding Jim Owens upon his retirement

Chemical Value Chain

H.B. Fuller Company announced that Celeste Mastin, Executive Vice President and Chief Operating Officer, will succeed Jim Owens as H.B. Fuller’s President and Chief Executive Officer, effective December 4, 2022. Upon assuming the role, Mastin will also join the Company’s Board of Directors, replacing Owens, who will be retiring.

October 2, 2022

LyondellBasell realigns executive team, forms circular and low-carbon solutions business

Chemical Value Chain

New LyondellBasell CEO Peter Vanacker, who joined the company from Neste in May, today named his senior executive team and outlined organizational changes, including creation of a circular and low-carbon solutions business. All changes will be effective 1 October.